Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmenting Language Therapy for Aphasia: A Randomized Double-Blind Placebo-Controlled Trial of Levodopa in Combination With Speech-Language Therapy

NCT01429077 is registered in ClinicalTrials.gov with Shirley Ryan AbilityLab as lead sponsor.

NCT NCT01429077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01429077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmenting Language Therapy for Aphasia: A Randomized Double-Blind Placebo-Controlled Trial of Levodopa in Combination With Speech-Language Therapy
Lead sponsor
Shirley Ryan AbilityLab
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2007
Completion date
March 31, 2012
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonfluent aphasia, stroke